IL173162A0
Methods for identifying compounds for regulating muscle mass or function using dopamine receptors
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
87 members in 9 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 34962002 | United States of America | P | |
| 29964202 | United States of America | A | |
| 0322588 | United States of America | W |
Members87
| Document | Office | Kind | |
|---|---|---|---|
| US2003140081A1 | United States of America | A1 | |
| WO03060704A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO03060711A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO03060712A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO03060724A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003205150A1 | Australia | A1 | |
| AU2003205150A8 | Australia | A8 | |
| AU2003207561A1 | Australia | A1 | |
| AU2003207561A8 | Australia | A8 | |
| AU2003214841A1 | Australia | A1 | |
| AU2003214841A8 | Australia | A8 | |
| AU2003216062A1 | Australia | A1 | |
| AU2003216062A8 | Australia | A8 | |
| US2003145035A1 | United States of America | A1 | |
| US2003145253A1 | United States of America | A1 | |
| WO03062991A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO03062993A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO03062995A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO03067852A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO03069475A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003205209A1 | Australia | A1 | |
| AU2003209249A1 | Australia | A1 | |
| AU2003224610A1 | Australia | A1 | |
| AU2003224610A8 | Australia | A8 | |
| AU2003236530A1 | Australia | A1 | |
| AU2003209028A1 | Australia | A1 | |
| US2003167257A1 | United States of America | A1 | |
| US2003167326A1 | United States of America | A1 | |
| US2003167353A1 | United States of America | A1 | |
| US2003170741A1 | United States of America | A1 | |
| US2003172172A1 | United States of America | A1 | |
| US2003177197A1 | United States of America | A1 | |
| US2003177284A1 | United States of America | A1 | |
| WO03077127A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003210522A1 | Australia | A1 | |
| US2003182403A1 | United States of America | A1 | |
| US2003187869A1 | United States of America | A1 | |
| WO03060704A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO03060711A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO03062993A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2004027638A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2003267220A1 | Australia | A1 | |
| WO03060712A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO03077127A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2004068277A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO03069475A3 | World Intellectual Property Organization (WIPO) | A3 | |
| AU2003303102A1 | Australia | A1 | |
| AU2003303102A8 | Australia | A8 | |
| WO03067852A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO03062991A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO03060724A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO03062995A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1474762A2 | European Patent Office (EPO) | A2 | |
| WO2004068277A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1493102A2 | European Patent Office (EPO) | A2 | |
| TW200504363A | Taiwan Province of China | A | |
| EP1502207A2 | European Patent Office (EPO) | A2 | |
| CA2532553A1 | Canada | A1 | |
| WO2005017484A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003256621A1 | Australia | A1 | |
| US2005080911A1 | United States of America | A1 | |
| EP1546911A1 | European Patent Office (EPO) | A1 | |
| CN1639714A | China | A | |
| CN1695135A | China | A | |
| IS8236A | Iceland | A | |
| US2006021026A1 | United States of America | A1 | |
| CN1751307A | China | A | |
| EP1646856A2 | European Patent Office (EPO) | A2 | |
| CN1774703A | China | A | |
| IL173162A0This record | Israel | A0 | |
| US7067113B2 | United States of America | B2 | |
| US7073178B2 | United States of America | B2 | |
| US2006183735A1 | United States of America | A1 | |
| US2006200562A1 | United States of America | A1 | |
| US7117506B2 | United States of America | B2 | |
| US7130872B2 | United States of America | B2 | |
| US2006253461A1 | United States of America | A1 | |
| US7168008B2 | United States of America | B2 | |
| EP1546911A4 | European Patent Office (EPO) | A4 | |
| WO2005017484A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US7246360B2 | United States of America | B2 | |
| US2007192772A1 | United States of America | A1 | |
| US7299472B2 | United States of America | B2 | |
| CN101084436A | China | A | |
| US7469300B2 | United States of America | B2 | |
| CN100514309C | China | C | |
| US7818758B2 | United States of America | B2 |
Numbers
- Application
- 173162
Titles
- English
- METHODS FOR IDENTIFYING COMPOUNDS FOR REGULATING MUSCLE MASS OR FUNCTION USING DOPAMINE RECEPTORS
Classification
- CPC, 9
- C07K16/28
- A61K31/55
- C07K2317/21
- G01N33/6887
- G01N33/9413
- G01N2500/00
- G01N2800/2878
- G01N2800/2885
- A61P21/00
- IPC, 4
- A61K31 55
- C07K16 28
- G01N33 68
- G01N33 94